GI & Endoscopy

Here are the five most popular Becker's ASC Review gastroenterology and endoscopy stories for the week of May 2 to May 6, 2016.

GI Dynamics appointed Jim Murphy as CFO.

Laboratory Corporation of America, a healthcare diagnostics, is the first United States-based laboratory to offer Epi proColon, a blood-based test for colorectal cancer screening.

Current Medicare beneficiaries, particularly those in a low-income bracket, lacking supplemental insurance may not be able to afford colon cancer screening and treatment, according to a study in Gastroenterology.

Here are three gastroenterologists who recently made headlines.

A study published in the journal Clinical Gastroenterology and Hepatology found that after adjustment for confounding variables there is no correlation between the risk of Barrett's esophagus and tea or coffee consumption.

Luis A. Balart, MD, is a gastroenterologist and chief of the section of gastroenterology and hepatology at Tulane University School of Medicine in New Orleans.

Crospon received FDA clearance for expanded indications of use for its EndoFLIP endolumenal imaging system.

A pilot study found that a majority of children with recurring Clostridium difficile infections who received a fecal microbiota transplant had no C. Difficile episodes for months following the procedure, according to a Medscape report.

The GI Quality Improvement Consortium registry reached 3 million reported colonoscopy cases in April.